Malignant lymphomas of T-NK cell origin bear CD56, as well as multiple myeloma, melanoma and some cancers of epithelial origin, which suggests that CD56 is involved in tumor biology in some unknown manner [12]. This evidence concerns the gene NCAM1 and lymphoma.